Page 89 - Sohini Das

Covid winter sparks scramble for pvt hospital beds in Delhi, Mumbai stable

Delhi reels under a strong second wave of infections with daily tally of over 8,000 cases, Mumbai seems to be breathing easy with almost one-eighth that number

Serum to have 200 mn doses of AstraZeneca coronavirus vaccine ready by Jan

Pune company recruits over 1,600 participants in India for phase 3 trials of Covishield.

Govt announces Rs 900 cr towards research, development of Covid-19 vaccine

The funds for research have been allocated to the Department of Biotechnology as part of the stimulus package announced by the finance minister

Pandemic pushes up demand for CT scanners; firms gear up to meet surge

For Siemens, around 50 per cent are first-time buyers, 30 per cent are adding machines for Covid-19

India's largest pharma IPO worth Rs 6,500 cr set to hit market next week

Fosun-owned Gland Pharma sets price band for its IPO at Rs 1,490-1,500 per share

Sun Pharma's Q2 net profit rises 70% on one-time tax credit

Revenues remain flat, sequential improvement in India and US revenues

Listing can happen in 18-24 months, says Manipal Education's Ranjan Pai

Our focus right now is to complete the transaction and the integration, said Pai

Bengaluru-based Manipal Hospitals to acquire Columbia Asia for Rs 2,100 cr

The deal may mark the exit of US based hospital chain from India

DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir

Emergency use authorisation to continue; recently, WHO had raised doubts about efficacy of drug in treatment of Covid-19 patients

Covid-19 vaccine: India begins augmenting its cold chain capacity

While the country already has a huge cold chain set-up, it may not be enough for vaccine delivery

Decoded: Why the fear of a second coronavirus wave in India is real

Europe is now suffering from a second wave of the Sars-CoV-2 virus attack

Govt revises PLI scheme for bulk drugs to boost local manufacturing

Industry says revised PLI scheme will attract more MSMEs to invest as minimum investment clause done away with

Syringe, vial makers ramp up capacity amid Covid-19 vaccine hopes

The first of a two-part series looks at the ways in which the supply chain for the delivery of the Covid-19 vaccine is being bolstered

Covid-19: Dr Reddy's engages Indian partners to develop Sputnik V

Sputnik V is also undergoing Phase 3 clinical trials in Russia and other parts of the globe on 40,000 volunteers

Aurobindo Pharma to sell US-based Natrol for about Rs 4,048 crore

Aurobindo's stock reacted positively to the news, going up in morning trade but later settled flat at Rs 784.65 on the BSE

Investigational therapy: Ozone next in the mix to help fight Covid-19

It has the potential of an immunity-boosting prophylactic and can help ease post-Covid-19 complications

Bharat Biotech starts Covaxin's at-risk manufacturing; expanding capacity

The first vaccine candidate will be an intra-muscular one, followed by intra-dermal and nasal ones, depending on test results.

Covid-19: Bharat Biotech cuts Covaxin phase-2 clinical trial size by half

For phase-2 studies, the firm is also testing the vaccine on children above 12 years of age. In phase-1, they only tested adults.

Indian samples of global Covid-19 vaccines need to be larger: Experts

Indian players like Bharat Biotech and Zydus Cadila ready for large-scale phase-3 trials

Smaller pharma firms post faster domestic sales growth in September

Barring Cipla and Glenmark, whose sales have grown in double digits due to demand for their Covid-19 drugs like favipiravir, tocilizumab, most big players have posted tepid growth